S
Subash
About Subash
Data last updated:
Subash is a Whole-Time Director at Medsum Legal Private Limited (since 2022). The companies operate in Healthcare. Medsum Legal Private Limited reported revenue of ₹4.07 Cr (FY 2025). Earlier, Subash was a Director at Mrr Health Tech Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 15 Apr 2022 | 2020 | ₹4.07 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jan 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Duraipandi | 08631499 | Medsum Legal Private Limited | Managing Director |
| Irulappan Suganya | 08834330 | Medsum Legal Private Limited | Director |
| Kavimani Sivan | 08834331 | Medsum Legal Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subash
Subash currently holds 1 directorship: Medsum Legal Private Limited (Whole-Time Director, since 15 Apr 2022, revenue ₹4.07 Cr (FY 2025)).
Subash was first appointed on 04 Jan 2019 as Director at Mrr Health Tech Private Limited. The most recent appointment on record is 15 Apr 2022 at Medsum Legal Private Limited.
Subash held 1 earlier board appointment: Mrr Health Tech Private Limited (Director, from 04 Jan 2019).
The current boards of Subash's companies include Duraipandi (Medsum Legal Private Limited), Irulappan Suganya (Medsum Legal Private Limited), Kavimani Sivan (Medsum Legal Private Limited).